Your browser doesn't support javascript.
loading
POF (paclitaxel/oxaliplatin/5-fluorouracil/leucovorin) vs. SOX/CAPOX/FOLFOX as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer: Study protocol for a randomized controlled trial, FNF-014 trial.
Su, Liyu; Zhao, Shen; Yin, Yi; Huang, Feng; Zhu, Jinfeng; Chen, Luchuan; Lin, Rongbo.
Affiliation
  • Su L; Department of Gastrointestinal Medical Oncology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Zhao S; Department of Gastrointestinal Medical Oncology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Yin Y; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
  • Huang F; Department of Gastrointestinal Medical Oncology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Zhu J; Department of Gastrointestinal Surgical Oncology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Chen L; Department of Medical Oncology, Quanzhou First Hospital, Quanzhou, China.
Front Med (Lausanne) ; 9: 861777, 2022.
Article in En | MEDLINE | ID: mdl-35983099
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Front Med (Lausanne) Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Front Med (Lausanne) Year: 2022 Document type: Article Affiliation country: China